Relative and disease-free survival for breast cancer in relation to subtype: a population-based study

被引：0
作者：
Pamela Minicozzi
Francesca Bella
Angela Toss
Adriano Giacomin
Mario Fusco
Maurizio Zarcone
Rosario Tumino
Fabio Falcini
Rosaria Cesaraccio
Giuseppa Candela
Francesco La Rosa
Massimo Federico
Milena Sant
机构：
[1] Fondazione IRCCS Istituto Nazionale dei Tumori,Analytical Epidemiology and Health Impact Unit, Department of Preventive and Predictive Medicine
[2] University of Modena and Reggio Emilia,Department of Oncology, Hematology and Respiratory Diseases
[3] Province of Biella (CPO),Piedmont Cancer Registry
[4] Epidemiology Unit,Campania Cancer Registry
[5] Local Health Unit Napoli 3 South,Palermo Breast Cancer Registry, Department of Oncology
[6] “ARNAS Civico” Hospital,Epidemiology and Prevention Unit, Department of Preventive and Predictive Medicine
[7] Fondazione IRCCS Istituto Nazionale dei Tumori,Cancer Registry and Histopathology Unit
[8] “MP Arezzo” Civic Hospital,Romagna Cancer Registry
[9] Provincial Health Unit,Sassari Cancer Registry, Epidemiology Unit
[10] IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori,Trapani Cancer Registry
[11] Local Health Unit 1,Department of Surgical and Medical Specialties and Public Health
[12] Provincial Health Unit,undefined
[13] University of Perugia,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2013年 / 139卷
关键词：
Breast cancer; HER2; Hormone receptor; Ki67; Population-based study; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1569 / 1577
页数：8
相关论文
共 324 条
[1]  
Ahlin C(2007)Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values? Histopathology 51 491-498
[2]  
Aaltonen K(2011)Italian cancer figures, report 2011: survival of cancer patients in Italy Epidemiol Prev 35 1-200
[3]  
Amini RM(2009)New incidence and mortality data 2003–2005 Epidemiol e Prev 33 e1-3
[4]  
Nevanlinna H(2004)Prognostic value of morphology and hormone receptor status in breast cancer—a population-based study Br J Cancer 91 1263-1268
[5]  
Fjällskog ML(2008)Reasons for breast cancer heterogeneity J Biol 7 6-vi12
[6]  
Blomqvist C(2012)Triple-negative breast cancer: epidemiological considerations and recommendations Ann Oncol 23 vi7-2584
[7]  
Allemani C(2012)Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers Ann Oncol 23 2578-758
[8]  
Sant M(2011)Female breast cancer status according to ER, PR and HER2 expression: a population based analysis Pathol Oncol Res 17 753-2502
[9]  
Berrino F(2006)Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2492-750
[10]  
Aareleid T(2009)Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer J Natl Cancer Inst 101 736-64
12345678910